Non-profit Vaccine Hub EVI operates as a coordinating hub for EU and global vaccine R&D, presenting opportunities to partner with a network of major organizations and consortia that fund and accelerate vaccine development for diseases of poverty.

Strategic Partnerships Recent and ongoing collaborations with organizations like Fondation pour la Recherche Médicale, Hilleman Laboratories, Merck Millipore, and TransVAC indicate a receptive environment for co-development, manufacturing partnerships, and funded research initiatives.

Funding & Collaboration EVI’s role in coordinating externally funded consortia suggests potential for joint grant opportunities, sponsored research, and cost-sharing programs that can be leveraged to expand vaccine formulation, formulation development, and clinical testing efforts.

Mid-market Footprint With an employee base in the 11-50 range and revenue between one and ten million, EVI sits between small specialized agencies and larger players, offering a clean entry point for partner-supplier engagements and pilot projects.

Technical Readiness The tech stack (Drupal, PHP, open graph tools) and collaboration platforms (LogMeIn, Sentry) indicate readiness for digital collaboration, data sharing, and stakeholder outreach initiatives—opportunities to propose secure data management, reporting dashboards, and partner portals.